FindTrial
Sign In

Effect of yoga breathing and pulmonary rehabilitation in AECOPD patients.

Efficacy of Yoga based Breathing and Pulmonary Rehabilitation versus Pulmonary Rehabilitation alone on Respiratory Muscle Strength in Patients of Acute Exacerbation of COPD - A Randomized Controlled Trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078027
Enrollment
150
Registered
2024-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J441- Chronic obstructive pulmonary disease with (acute) exacerbation

Interventions

Intervention1: Yoga-based breathing and Pulmonary rehabilitation: The total duration of the intervention is 45 minutes, structured to incorporate a combination of warm-up exercises, physical activity,

Sponsors

AIIMS Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1) Both genders of age range 40-75 years old. 2) Individuals admitted with the diagnosis of AECOPD. 3) Individuals should be able to perform spirometry, MIP/MEP, and 6MWD. 4) Consenting

Exclusion criteria

Exclusion criteria: Exclusion criteria 1) Muscular/neurological/neuromuscular disease 2) Unable to perform rehabilitation/yoga 3) Patients or caretakers do not have access to smart phones 4) Uncontrolled DM/severe co-morbidities (IHD/CKD/CLD), arrhythmia, severe hypertension, acute pulmonary embolism, any known malignancy with a short life expectancy, and acute heart failure.

Design outcomes

Primary

MeasureTime frame
Primary outcome for this trial will be the change in respiratory muscle strength including Maximal Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP) among AECOPD patients.Timepoint: outcomes will be recorded on baseline and 8 weeks.—

Secondary

MeasureTime frame
Secondary outcomes for this study will be following: 1. Symptom score - mMRC Dyspnea, BORG Scale 2. GAD-7 for Generalized Anxiety Disorder 3. Patient Health Questionnaire (PHQ-9) for Depression 4. Health-related quality of life (SGRQ) 5. Partial pressure of Carbon dioxide (PCO2) 6. C-Reactive Protein (CRP) 7. Spirometry Variables: FEV1%, FVC, FEV1/FVC 8. 6-minute walk distance (6MWD) with BORG scale 9. Adverse Events (Deaths, emergency visits, readmission rate) Timepoint: 8 weeks—

Countries

India

Contacts

Public ContactDr Ruchi Dua

AIIMS Rishikesh

Ruchi.pulm@aiimsrishikesh.edu.in7895973469

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026